GeneNews' Q3 Revenues Fall 74 Percent; PGx, MDx Services Launched | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneNews' third-quarter revenues plummeted 74 percent year over year, the Canadian developer of blood-based biomarker tests reported after the close of the market on Thursday.

In a document filed with Canadian regulators, the company said that revenues in the quarter totaled C$43,999 (US$44,241), down from C$166,515 a year ago as non-refundable licensing revenues dropped to zero from C$162,619 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.